Press Release
Best in Class: Scottsdale Wound Management Guide
Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips
Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More
2009 WOUNDS Article Index
Non-Accredited Education
Simple Steps in Wound Healing to Achieve Success for Your Patients and Practice - Complimentary On-Demand Webcast
Non-Accredited
Managing the Diabetic Foot: A Clinical and Economic View Complimentary Archived Webcast
Non-Accredited
Managing the Diabetic Foot: A Clinical and Economic View Complimentary Archived Webcast
Non-Accredited
CLINICAL EVENTS CALENDAR
- SAWC/WHS Spring 2010Start Date:April 17, 2010End Date:April 20, 2010
Gaylord Palms, Orlando, FL
- Wound Clinic Business
Ortec Partners with PDI for Launch of OrCel into Burn Market
Ortec International, Inc., a tissue-engineering company, announced that it will use a dedicated sales force provided by PDI, a pharmaceutical and medical device and diagnostics sales and marketing company, to target the donor site burn market. OrCel™, a biologically active wound agent, will be launched during the first quarter of 2002 throughout the United States. OrCel is the only product containing living human cells approved by the FDA for healing donor site wounds in burn patients.
Ortec International, Inc., is a tissue-engineering company involved in the commercialization of a proprietary and patented technology to stimulate the repair and regeneration of human tissue. Ortec’s current focus is the application of OrCel to heal chronic and acute wounds. In addition to having received FDA approvals this year for OrCel for treatment of epidermolysis bullosa and donor sites in burn patients, Ortec is also pursuing FDA approvals for venous and diabetic skin ulcers and is in the midst of clinical trials for these indications. Ortec believes that its platform technology extends to the regeneration of other human tissue, such as tendons, ligaments, cartilage, bone, muscle, and blood vessels. For more information, visit www.ortecinternational.com.
- Login or register to post comments
- Email this page
WOUNDS Monthly Poll
Anytown, California
WOUNDS News Wire
- Wednesday, March 3, 2010 - 14:13
- Friday, January 22, 2010 - 14:34
- Tuesday, November 24, 2009 - 10:30
CME Showcase
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
A Complimentary On-Demand CE/CME Webcast This activity is supported by an educational grant from Advanced Biohealing. To access this Webcast, visit www.naccme.com/program/n-550/ |

















